Shopping Cart
- Remove All
- Your shopping cart is currently empty
ZB-R-55 is an orally available and highly potent bimodal RIPK1 inhibitor with excellent kinase selectivity in lps-induced sepsis models for the study of SIRS and sepsis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $333 | In Stock | |
5 mg | $987 | In Stock | |
10 mg | $1,360 | In Stock | |
25 mg | $1,980 | In Stock | |
50 mg | $2,720 | In Stock | |
100 mg | $3,680 | In Stock |
Description | ZB-R-55 is an orally available and highly potent bimodal RIPK1 inhibitor with excellent kinase selectivity in lps-induced sepsis models for the study of SIRS and sepsis. |
In vitro | ZB-R-55 exhibits 10 times greater inhibitory activity against RIPK1 compared to GSK2982772, demonstrating exceptional kinase selectivity.[1] |
In vivo | In an LPS/TNF-α-induced sepsis mouse model, oral administration of ZB-R-55 (10 mg/kg) significantly alleviated hypothermia, reduced cytokine storm, and improved survival rate. [2] |
Alias | ZBR-55, ZB-R55 |
Molecular Weight | 441.48 |
Formula | C25H23N5O3 |
Cas No. | 2416593-55-8 |
Smiles | CN1C=2C(OC[C@H](NC(=O)C=3NC(CC4=CC=CC=C4)=NN3)C1=O)=CC=C(C#CC5CC5)C2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (181.21 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.